Skip to main content
Drug Development
Our Pipeline
Evaluation Pipeline
Inaphaea BioLabs
Therapeutic areas
Partnering
Useful Links
News
Investors
Regulatory News
AIM Rule 26
Annual and Half Yearly Reports
Admission Document & Articles
Shareholder communications
Investments Calculator
Share Alerts
Share Series
Share price look-up
Analyst Research
About us
Board of Directors and Management Team
Strategy and Vision
How we work
Working with us
Collaborative Pipeline
Contact us
Search
News
Breadcrumb
News
Category
Articles
Events and presentations
News
Press releases
Videos and audiocasts
Articles
Meet the ValiRx team: Dr Suzy Dilly
19 May 2023
News
2023 events round-up: ValiRx and Inaphaea BioLabs
16 May 2023
Articles
Meet the ValiRx team: Kumar Nawani
3 May 2023
News
ValiRx and Physiomics join forces to provide seamless data integration
26 Apr 2023
Articles
Meet the Inaphaea BioLabs team: Dr Andrew Carnegie
21 Apr 2023
News
Article by Dr Cathy Tralau-Stewart published by European Pharmaceutical Manufacturer
12 Apr 2023
Articles
Meet the ValiRx team: Zai Ahmad
3 Apr 2023
News
Spring Budget key messages: R&D tax relief rate
30 Mar 2023
News
ValiRx CEO attends Treasury Connect: Life Sciences Conference
30 Mar 2023
Videos and audiocasts
ValiRx Investor Webinar Presentation with Q&A held on 8th March 2023
9 Mar 2023
Articles
International Women’s Day 2023: carving out a career in the life sciences
8 Mar 2023
News
ValiRx bolsters Inaphaea with trio of appointments
6 Mar 2023
Articles
Meet the ValiRx team: Mark Treharne
27 Feb 2023
Videos and audiocasts
Operational Update Videocast
31 Jan 2023
Pagination
Current page
1
Page
2
Page
3
Page
4
Page
5
Next page
Next
Last page
Last
